Archive
Back to homepageModerna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine
CAMBRIDGE, Mass. and INCHEON, South Korea, May 23, 2021 /PRNewswire/ — Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics (KRX: 207940.KS), a leading global CDMO providing a fully integrated end-to-end contract development and
Read MoreAsian Enterprise of Tomorrow Conference Gathers Global Wisdom for Entrepreneurship in China’s Chongqing
CHONGQING, China, May 22, 2021 /PRNewswire/ — A news report by iChongqing: On conclusion of the 2021 Asian Enterprise of Tomorrow Conference (AEOT) held under the banner of the 3rd Western China International Fair for Investment and Trade (WCIFIT), over 200 Asian corporate
Read More
